Limiting Toxicity in Limited-Stage Hodgkin Lymphoma
Hear findings, discussed by Jeremy Slade Abramson, MD, from a phase II trial comparing brentuximab vedotin with or without AVD radiation therapy for reducing the adverse effects of radiation and bleom...
Author: ash
Added: 10/08/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts